Box 3 Meds Flashcards
(32 cards)
Labetalol (Normodyne, Trandate) Class
Non-selective beta adrenergic blocker (w/ some alpha 1-blocking properties)
Labetalol (Normodyne, Trandate) MOA
Competitive beta receptor antagonist & prevent actions of catecholamine and other beta agonists
Labetalol (Normodyne, Trandate) Dosage
IV: 0.1-0.5 mg/kg (20-80 mg bolus q 10)
Labetalol (Normodyne, Trandate) characteristics
O: 5 min or less
P: 5-15 min
D: 2-6 hrs
Labetalol (Normodyne, Trandate) E/M
M: conjugation w/ glucuronic acid (hepatic)
E: renal
H/t: 5-8 hrs
Labetalol (Normodyne, Trandate) considerations
Provides b blockade in a 7:1 ratio IV but 3:1 PO
Elimination prolonged in liver dz but unchanged in renal
Contra: bronchospasm, 1 degree HB, cardio genic shock, obs. airway dz, severe bradycardia
Metoprolol (Lopressor, Troprol XL) Class
Selective B1-adrenergic antagonist (cardioselective)
Metoprolol (Lopressor, Toprol XL) MOA
Prevents inotropic & chronotropic response to B-adrenergic stimulation.
Metoprolol (Lopressor, Toprol XL) Dosage
IV: 1-15 mg
PO: 50-400mg
Metoprolol (Lopressor, Toprol XL) characteristics
O: 1-5 min
P: 20 min
D: 5-7 hrs
Metoprolol (Lopressor, Toprol XL) E/M
Undergoes first pass hepatic met. so only 40% reaches circulation
h/t: IV 3-7 hrs
PO tartrate: 2-3 hrs
PO succinate: 5-7 hrs
Metoprolol (Lopressor, Toprol XL) considerations
Caution w/ high doses in ch obstructive airway and hypoglycemic
Contra: AV HB, acute cardiac failure caused by tachycardia, hypovolemic pts w/ compensatory tachycardia (can cause resistant hypotension)
Neostigmine (Prostigmin) class
Anticholinesterase inhibitor
Neostigmine (Prostigmin) MOA
Inhibits AChE so that ACh accumulates at NMJ & competes w/ nondepolarizing NMB for unoccupied nicotinic ACh receptors
Neostigmine (Prostigmin) dosage
Most common 40-70 mcg/kg
MAX: 5mg
Neostigmine (Prostigmin) E/M
Renal excretion 50%
Neostigmine (Prostigmin) considerations
MUST have at least 1 twitch first.
To minimize muscarinic CV effects, an anticholinergic (glycopyrrolate 7-15mcg/kg) should be coadministered
Caution in brady, bronchial asthma, epilepsy, arrhythmia, peptic ulcer, peritonitis, mechanical obs of intestines
Robinul (Glycopyrrolate) class
Systemic cholinergic antagonist
Robinul (glycopyrrolate) MOA
Blocks effects of ACh at parasympathetic sites.
Reduces rate of salivation by preventing stimulation of ACh receptors
Robinul (glycopyrrolate) Dosage
IV: 7-15 mcg/kg
Robinul (glycopyrrolate) characteristics
O: IV 2 min; IM/subq 15-30 min
P: 30-45 min
D: 2-4 hrs
Robinul (glycopyrrolate) E/M
Feces (15%), urine (85%)
Robinul (glycopyrrolate) considerations
Unlikely to pass BBB, GIT, or placenta d/t ionization (insoluble in lipids)
Mod increase in HR (
Robinul (glycopyrrolate) supply
0.2mg/ml or 0.4mg/ml